Compile Data Set for Download or QSAR
Report error Found 22 Enz. Inhib. hit(s) with all data for entry = 12232
TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689117(US20240190904, Example A12)
Affinity DataKd:  2.30nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689127(US20240190904, Example B1)
Affinity DataKd:  3.20E+3nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689126(US20240190904, Example A26)
Affinity DataKd:  12nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689125(US20240190904, Example A25)
Affinity DataKd:  6.40nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689124(US20240190904, Example A24)
Affinity DataKd:  5.20nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689123(US20240190904, Example A21)
Affinity DataKd:  1.5nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689122(US20240190904, Example A20)
Affinity DataKd:  8.70nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689121(US20240190904, Example A16)
Affinity DataKd:  3.80nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689120(US20240190904, Example A15)
Affinity DataKd:  3nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689119(US20240190904, Example A14)
Affinity DataKd:  3nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689118(US20240190904, Example A13)
Affinity DataKd:  1.40nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689106(US20240190904, Example A1)
Affinity DataKd:  28nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689116(US20240190904, Example A11)
Affinity DataKd:  3nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689115(US20240190904, Example A10)
Affinity DataKd:  1.80nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689114(US20240190904, Example A9)
Affinity DataKd:  2.10nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689113(US20240190904, Example A8)
Affinity DataKd:  2nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689112(US20240190904, Example A7)
Affinity DataKd:  5.80nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689111(US20240190904, Example A6)
Affinity DataKd:  3.10nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689110(US20240190904, Example A5)
Affinity DataKd:  120nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689109(US20240190904, Example A4)
Affinity DataKd:  89nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689108(US20240190904, Example A3)
Affinity DataKd:  430nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Accro Bioscience (HK)

US Patent
LigandPNGBDBM689107(US20240190904, Example A2)
Affinity DataKd:  89nMAssay Description:For most assays, kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent